Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial

Background/Aim:   Telmisartan can attenuate two hit pathogenesis of non-alcoholic steatohepatitis (NASH). This study aimed to observe the effect of Telmisartan on non-alcoholic fatty liver disease (NAFLD) activity score (NAS) and fibrosis score in NASH patients. Patients and Methods: A total of 50 N...

Full description

Bibliographic Details
Main Authors: Shahinul Alam, Jahangir Kabir, Golam Mustafa, UtpalDas Gupta, SKMNazmul Hasan, AKMKhorshed Alam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2016;volume=22;issue=1;spage=69;epage=76;aulast=Alam